Index Adjustments on the Occasion of the Ordinary Index Review

The Management Committee of Financial Information has decided to make changes to the index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 18 September 2020 after closing. The adjustment takes effect on 21 September 2020.

Index Adjustments on the Occasion of the Ordinary Index Review
Published at
Medium
Trade Media

Changes to the SMI® and SPI®20 index baskets

Admission to the SMI® and SPI®20

PARTNERS GROUP N

 CH0024608827


Exclusion from the SMI® and SPI®20

ADECCO N

CH0012138605


Changes to the SMIM® index basket

Admission to the SMIM®

ADECCO N

CH0012138605

SIG Combibloc Grp N

CH0435377954

GALENICA N

CH0360674466

CEMBRA MONEY BANK N

 CH0225173167


Exclusion from the SMIM®

PARTNERS GROUP N

CH0024608827

SWATCH GROUP N

CH0012255144

BUCHER N

CH0002432174

dormakaba N

 CH0011795959


Changes to the SLI® index basket

Admission to the SLI®

STRAUMANN N

 CH0012280076


Exclusion from the SLI®

VIFOR N

 CH0364749348


SLI® 9% cappings

Based on the SLI® index rules, section 7.11.4, and according to the capping selection list 9%1, the weight of the following securities will be limited to 9%:

NESTLE N

CH0038863350

NOVARTIS N

CH0012005267

ROCHE GS

CH0012032048

ZURICH INSURANCE N

CH0011075394


Changes to the SPI® Small, Mid and Large index baskets

Changes from SPI® Mid to SPI® Large

SONOVA N

CH0012549785


Changes from SPI® Large to SPI® Mid

SWATCH GROUP I

CH0012255151


Changes from SPI® Small to SPI® Mid

BACHEM N -B-

CH0012530207

JUNGFRAUBAHN HLD N

CH0017875789

INTERSHOP N

CH0273774791

ARBONIA N

 CH0110240600

ZUG ESTATES HOLDING AG

CH0148052126


Changes from SPI® Mid to SPI® Small

GAM N

CH0102659627

COSMO PHARM N

NL0011832936

IMPLENIA N

CH0023868554

BOBST GRP N

 CH0012684657

Metall Zug AG

CH0039821084


Changes to the SXI Life Sciences®

Admission to the SXI Life Sciences®

SANTHERA N

 CH0027148649


Exclusion from the SXI Life Sciences®

NEWRON PHARMA N

 IT0004147952

Polyphor N

 CH0106213793


Changes to the SXI Bio+Medtech®

Admission to the SXI Bio+Medtech®

SANTHERA N

 CH0027148649


Exclusion from the SXI Bio+Medtech®

NEWRON PHARMA N

 IT0004147952

Polyphor N

 CH0106213793

 

Changes to the SXI Swiss Real Estate® Funds and SXI Swiss Real Estate® Shares

NO CHANGES TO THE INDEX COMPOSITION

 

Further Links

The equity selection list, which is compiled four times a year on the basis of the admission and exclusion criteria, is available on the website[1]:

 

1 Access to the Closed User Group required.

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX serves the Swiss and Spanish financial centers and a broad international client base, offering stable and efficient infrastructure services. SIX operates stock exchanges and provides services in securities, financial information as well as the payments business. The company is owned by its users (about 120 financial institutions). With over 4,400 employees and a presence in 20 countries, SIX generated operating income of CHF 1.6 billion and EBITDA of CHF 443.7 million in 2024.
www.six-group.com

View all Media Releases